The Efficacy of Surgical Site Treatment With Ropivacaine in Laparoscopic Surgery
- Conditions
- Pain
- Interventions
- Drug: Topical useOther: laparoscopic repair of inguinal herniaOther: laparoscopic bariatric surgery
- Registration Number
- NCT02826876
- Lead Sponsor
- Western Galilee Hospital-Nahariya
- Brief Summary
Using local analgesia in laparoscopic surgery in order to reduce pain and to reduce the use of narcotic drugs.
- Detailed Description
At the end of laparoscopic surgery the investigators will spray ropivacaine in the surgical site; and later the investigators will monitor pain intensity and use of analgesic drugs
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
- Laparoscopic bariatric surgery
- Laparoscopic inguinal hernia surgery
- Cardiac arrythmias
- Active ischemic heart disease
- pregnancy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Ropivacaine Topical use Topical use of Ropivacaine Ropivacaine laparoscopic bariatric surgery Topical use of Ropivacaine Placebo Topical use Topical use of placebo Placebo laparoscopic repair of inguinal hernia Topical use of placebo Placebo laparoscopic bariatric surgery Topical use of placebo Ropivacaine laparoscopic repair of inguinal hernia Topical use of Ropivacaine
- Primary Outcome Measures
Name Time Method Pain scale as measured by pain scale questionnaire 1 Week post operative pain intensity will be assisted by VAS(visual analog pain scale) scale at fixed times after surgery
- Secondary Outcome Measures
Name Time Method Reducing use of narcotics according to nurse records 1 Week patients will be treated by standard analgetic protocol, the records of analgetic drugs will be collected during patients hospitalization
Trial Locations
- Locations (1)
Naharia Medical Center
🇮🇱Naharia, Israel